Penguatkuasaan keperluan kajian bioekuivalens (BE) dan akreditasi pusat kajian BE bagi produk generik tetapi produk inovator tidak pernah didaftarkan di Malaysia
The Government of Malaysia and the National Pharmaceutical Regulatory Agency are not responsible for any loss or damage caused by the usage of any information obtained from this website.
Mobile Web :
Site Last Modified
Last Modified: Monday 25 September 2023, 14:20:55.